TickerFactsScreenerDevelopers

Inmune Bio, Inc. (INMB) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2016: -$149.2K2017: $18.10M2018: $16.54M2019: $23.61M2020: $38.75M2021: $80.22M2022: $60.10M2023: $37.34M2024: $32.10M2025: $23.52M$23.52M
2016Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$23.52M-26.7%
2024$32.10M-14.0%
2023$37.34M-37.9%
2022$60.10M-25.1%
2021$80.22M+107.0%
2020$38.75M+64.1%
2019$23.61M+42.7%
2018$16.54M-8.6%
2017$18.10M+12233.6%
2016-$149.2K—